Back to Agenda
S8 - Global Regulatory Trends and Standardization Strategies for Next-Generation Alternative Technologies
Session Chair(s)
In-sook Park, PHD
Former Director General, Korean Regulatory Science Center, Korea, Republic of
Sang Aeh Park
Director, MFDS, Korea, Republic of
Speaker(s)
Joohwan Kim
Depury Director, Nonclinical Resource Research Division, NIFDS, MFDS, Korea, Republic of
Beyond 3Rs: Transitioning to Human-Centric Toxicity Platforms through Regulatory Science Integration of NAMs
Danilo Tagle, PHD
Director, Office of Special Initiative, National Center For Advancing Translational Sciences (NCATS), NIH, United States
Validation and Qualification of NAMs towards Regulatory Acceptance and Widespread Adoption
Dean Smith, PHD
Advisor to the Director & Sr. Evaluator, Health Canada, Centre for Vaccines, Clinical Trials & Biostatistics, Canada
NAMs: Regulatory Science Alternatives
Ran Noh, MS
Team Manager, Korea Biomedicine Industry Association (KoBIA), Korea, Republic of
Global Trends in NAMs and Industry Perspectives on Key Challenges
Jaeok Kim
Director, Biologics Division, NIFDS, MFDS, Korea, Republic of
Have an account?